Biomerica Reports 111% Increase in Q3 Fiscal 2022 Revenues to $7.6 million vs. Q3 Fiscal 2021 Q3 Net loss per share of $0.01 vs. a net loss of $0.18 per share from same period last year InFoods® IBS diagnostic-guided therapy clinical trial results demonstrated statistically significant...

Highmark Interactive Announces Collaboration with Mayo Clinic to Assess Impact of "Long COVID" on Cognitive Function TORONTO, Oct. 05, 2021 (GLOBE NEWSWIRE) -- BrainFx, a wholly owned subsidiary of Highmark Interactive, today announces its collaboration with Mayo Clinic to assess the impact of "Long COVID" or...

Rancho Santa Fe Bio, Inc. Enters into Worldwide Exclusive License Agreement with Sanofi for Ataciguat SAN DIEGO and PARIS, June 17, 2021 (GLOBE NEWSWIRE) -- Rancho Santa Fe Bio, Inc. (“RSF Bio” or the “Company”), a San Diego, California-based clinical-stage cardiovascular platform company, today...

New tools for predicting lupus flares now one step closer to market OKLAHOMA CITY, Nov. 27, 2017 (GLOBE NEWSWIRE) -- Lead investor i2E, along with Chicago-based OCA Ventures and Mayo Clinic Ventures, has funded the first round of investment to assist Progentec in...

Novel Findings Obtained with the PURE EP System to be Presented at American Heart Association’s BCVS Scientific Sessions 2017 Minneapolis, MN, June 26, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need...